Arcus Biosciences (RCUS) PT Raised to $54 at SVB Leerink
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $31.30 +1.29%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 42
Trade Now!
Join SI Premium – FREE
SVB Leerink analyst Geoffrey Porges raised the price target on Arcus Biosciences (NYSE: RCUS) to $54.00 (from $41.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
- SCREEN Holdings Co Ltd. (7735:JP) (DINRF) PT Raised to JPY12,300 at Macquarie
- Xero Limited (XRO:AU) (XROLF) PT Lowered to AUD153 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
